Drug details

Ondansetron Hydrochloride (Zofran) (ondansetron hydrochloride tablets)

type of

Ondansetron Hydrochloride Tablets are a selective 5-HT3 receptor antagonist indicated for prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin =50 mg/m2; prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy; prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen; and prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided postoperatively, ondansetron hydrochloride tablets are recommended even where the incidence of postoperative nausea and/or vomiting is low. Ondansetron is available in generic form. Common side effects of ondansetron include:

The following drugs are related to Ondansetron Hydrochloride (Zofran), either as a replacement or used together:

• Barhemsys (amisulpride injection, for intravenous use)